Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
3
×
life sciences
medicare
3
×
national blog main
national top stories
san francisco blog main
3
×
biotech
san francisco top stories
seattle blog main
seattle top stories
vc
2025
ad-comm
affimed
akcea therapeutics
allogene therapeutics
amicus therapeutics
andreessen horowitz
approval
apremilast
athenahealth
barack obama
base editing
bill frist
bio
biobucks
biogen
biome
blueprint medicineas
boston
boulder/denver blog main
boulder/denver top stories
briefing docs
calistoga pharmaceuticals
car-t
car-t immunotherapy
castlight health
celgene
cervical cancer
What
million
3
×
cancer
startup
therapeutics
adding
allogene
andreessen
answer
approach
bets
bio
boost
called
crispr
devoted
diversity
drug
expensive
far
fix
gilead
health
healthcare
health’s
hot
immunotherapy
industry
investors
involves
ipo
juno
leads
nearly
new
paying
pipeline
program
remains
roundup
sciences
Language
Current search:
medicare
×
million
×
" boston top stories "
×
" san francisco blog main "
×
@xconomy.com
5 years ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango
@xconomy.com
5 years ago
Andreessen Leads $300M Bet on Devoted Health’s Senior Care Approach
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More